Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial

Table 4 Postoperative outcomes

	Neostigmine group (n = 34)	Sugammadex group (n = 36)	p-value
Positive tongue depressor test^a	2 (5.9%)	5 (13.9%)	0.429
Positive swallowing test°	2 (5.9%)	4 (11.1%)	0.674
Desaturation after extubation (SpO2 < 90%)	0 (0%)	5 (13.9%)	0.054
PONV	2 (5.9%)	6 (16.7%)	0.261
Discharge to the ward with oxygen therapy	18 (52.9%)	22 (61.1%)	0.636
All respiratory complications	5 (14.7%)	5 (13.9%)	1.000
Acute respiratory insufficiency	1 (2.9%)	0 (0%)	0.486
Pneumothorax after chest tube removal	0 (0%)	1 (2.8%)	1.000
Pleural effusion	2 (5.9%)	3 (8.3%)	1.000
Atelectasis	1 (2.9%)	0 (0%)	0.486
Pneumonia	0 (0%)	1 (2.8%)	1.000
Chylothorax	1 (2.9%)	0 (0%)	0.486
Atrial fibrillation	0 (0%)	2 (5.5%)	0.493
Chest tube days	4 [2–5]	3.5 [3, 4]	0.990
Length of hospital stay (days)	5 [3.5–6]	4 [4, 5]	0.431
Clavien-Dindo grade at discharge
Grade 1	32 (94.1%)	32 (88.9%)
Grade 2	2 (5.9%)	3 (8.3%)
Grade 3	0 (0%)	1 (2.8%)
Clavien-Dindo grade at 30 days after surgery
Grade 1	31 (91.2%)	30 (83.3%)
Grade 2	3 (8.8%)	1 (2.8%)
Grade 3	0	1 (2.8%)
Data not reported	0	4 (11.1%)

^aDefined by the ability (negative test) or not (positive test) to hold the tongue depressor between the teeth at the experimenter’s pull
°Defined by the subjective ability (negative test) or not (positive test) to swallow 5 ml of water

ISSN: 2731-3786